Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NB600474PEP

Novus Biologicals™ c-Rel Antibody Blocking Peptide
SDP

Catalog No. NB600474PEP Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB600474PEP 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB600474PEP Supplier Novus Biologicals™ Supplier No. NB600474PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide from human REL. Source: Synthetic (Accession #: Q04864) The c-Rel Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 5966
Species Human
Purity >95%
Content And Storage Store at -20 C short term. Aliquot and store (at -80 C long term. Avoid freeze-thaw cycles.)
Formulation 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
For Use With (Application) Control Peptide Should be Used at 1.0 μg / 1.0 μL of Antiserum in / Assay.
Gene Alias C-Rel, C-Rel proto-oncogene protein, I-Rel, oncogene REL, avian reticuloendotheliosis, proto-oncogene c-Rel, v-rel avian reticuloendotheliosis viral oncogene homolog, v-rel reticuloendotheliosis viral oncogene homolog (avian)
Gene Symbol REL
Product Type c-Rel
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.